Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
17:29:08 EDT Tue 09 Jun 2026
Enter Symbol
or Name
USA
CA



Q:INSM - INSMED INC - https://www.insmed.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
INSM - Q0.496.00·98.930.699.04+4.875.24,240.2411,14539,45995.75  99.55  95.50212.75  70.5717:11:52Jun 0415 min RT 2¢

Recent Trades - Last 10 of 39459
Time ETExPriceChangeVolume
17:11:52Q98.924.754
17:11:08Q98.624.451
17:09:43Q98.834.6620
16:57:29Q99.044.8719,408
16:35:33Q98.834.6620
16:30:12Q100.155.985
16:29:43Q98.834.665
16:21:39Q98.834.6625
16:21:20Q98.834.6614
16:20:00Q99.044.872

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-06-04 07:00U:INSMNews ReleaseInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2026-05-27 07:00U:INSMNews ReleaseInsmed to Present at the 2026 Goldman Sachs Annual Global Healthcare Conference
2026-05-07 07:00U:INSMNews ReleaseInsmed Reports First-Quarter 2026 Financial Results and Provides Business Update
2026-05-06 16:30U:INSMNews ReleaseInsmed and Ty Pennington Team Up to Drive Awareness and Proper Diagnosis of Bronchiectasis
2026-05-04 07:00U:INSMNews ReleaseInsmed to Present Data Across Its Respiratory Portfolio, Including Late-Breaking ARIKAYCE(TM) Results from Phase 3b ENCORE Study, at the American Thoracic Society International Conference 2026
2026-04-30 07:00U:INSMNews ReleaseInsmed to Present at May 2026 Investor Conferences
2026-04-23 07:00U:INSMNews ReleaseInsmed to Host First-Quarter 2026 Financial Results Conference Call on Thursday, May 7, 2026
2026-04-07 16:01U:INSMNews ReleaseInsmed Provides Clinical Update on Phase 2b CEDAR Study
2026-03-23 07:00U:INSMNews ReleaseInsmed Announces Positive Topline Results from Phase 3b ENCORE Study of ARIKAYCE(TM) (Amikacin Liposome Inhalation Suspension) in Patients with MAC Lung Disease
2026-03-05 07:00U:INSMNews ReleaseInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2026-02-19 07:00U:INSMNews ReleaseInsmed Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides Business Update
2026-02-13 07:00U:INSMNews ReleaseInsmed To Present at March 2026 Investor Conferences
2026-02-05 07:00U:INSMNews ReleaseInsmed to Host Fourth-Quarter and Full-Year 2025 Financial Results Conference Call on Thursday, February 19, 2026
2026-01-28 07:00U:INSMNews ReleaseInsmed to Present Multiple Abstracts on Treprostinil Palmitil Inhalation Powder (TPIP) at Pulmonary Vascular Research Institute (PVRI) 2026 Congress
2026-01-09 07:00U:INSMNews ReleaseInsmed Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference
2026-01-02 07:00U:INSMNews ReleaseInsmed To Present at the 44th Annual J.P. Morgan Healthcare Conference
2025-12-17 16:01U:INSMNews ReleaseInsmed Provides Clinical and Business Update
2025-12-04 07:00U:INSMNews ReleaseInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2025-11-18 11:00U:INSMNews ReleaseEuropean Commission Approves BRINSUPRI(TM) (brensocatib) as the First and Only Treatment Approved for Non-Cystic Fibrosis Bronchiectasis in the European Union
2025-11-13 07:00U:INSMNews ReleaseInsmed Strengthens Communities Worldwide During Fourth Annual Global Day of Good